• Intas Pharmaceuticals Ltd., of Ahmedabad, India, and its subsidiary, Accord Healthcare Inc., said they entered a settlement and license agreement with Basel, Switzerland-based Roche AG to resolve pending patent litigation related to cancer drug Xeloda (capecitabine).